Trust Signals
- Written by the FormBlends Medical Team, reviewed May 2026.
- All vendors assessed against publicly available COAs, regulatory filings, and independent community testing reports.
- No vendor paid for placement. Rankings reflect documented quality criteria, not advertising relationships.
- Legal status of individual peptides is noted where it has materially changed in the last 24 months.
Key Takeaways
- Purity documentation via HPLC at 98% or above, with a named third-party lab on the COA, is the single most important quality filter when evaluating any US peptide supplier.
- The FDA removed semaglutide from its drug shortage list in early 2025, making most compounded semaglutide products illegal for 503A and 503B pharmacies to produce; this reshaped which peptides leading US companies actively supply.
- 503B outsourcing facilities are held to cGMP standards and FDA registration requirements, making them the highest-accountability option for compounded peptides when a prescription is involved.
- Research-grade vendors operate in a legal gray zone: "not for human use" labeling does not make a product safe or effective, and there is no federal quality floor for these products beyond what the vendor self-imposes.
- Cold-chain logistics during shipping (ice packs or dry ice) matter as much as storage conditions, because lyophilized peptides can begin to degrade at room temperature during prolonged transit.
What Are the Top 10 Peptide Companies in the USA Right Now?
Table of Contents
- How We Ranked: The Five Criteria That Actually Matter
- Evidence Ledger: What the Data Actually Says About Peptide Quality Claims
- Tier 1: FDA-Registered Compounding Pharmacies
- Tier 2: Research-Grade Peptide Vendors
- What Most Peptide Comparison Pages Get Wrong
- How to Read a Peptide COA Yourself
- Head-to-Head: Research Vendor vs. Compounding Pharmacy
- Why Storage and Shipping Chemistry Actually Matter
- Legal Landscape: What Changed in 2024 to 2026
- FAQ
- Sources
How We Ranked: The Five Criteria That Actually Matter
Most "best peptide company" lists rank based on marketing impressions or affiliate commissions. These five criteria are objective and verifiable:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- COA transparency. Is the COA publicly accessible (not just "available on request")? Does it name the testing laboratory? Does it include lot number and date? Can you independently verify the lab exists?
- Purity standard. HPLC purity at or above 98% with mass spectrometry confirmation of correct molecular weight. These are two different tests and both matter: HPLC measures purity, MS confirms identity.
- Regulatory posture. Does the company accurately describe the legal category of its products? Mislabeling a prescription-required compound as a "research chemical" is a legal and safety concern.
- Cold-chain logistics. Does the vendor offer cold-chain shipping for lyophilized peptides? Does packaging include temperature indicators?
- Endotoxin testing. Bacterial endotoxin (pyrogen) testing via Limulus Amebocyte Lysate (LAL) assay is standard for any compound that could enter the body. Its presence on a COA is a strong quality signal.
Evidence Ledger: What the Data Actually Says About Peptide Quality Claims
| Claim Often Made by Vendors | Best Evidence Type Available | Effect Direction | Confidence | Honest Caveat |
|---|---|---|---|---|
| HPLC purity above 98% ensures product is safe | Analytical chemistry standard (USP) | Necessary but not sufficient | Moderate | Purity confirms the right molecule is present; it does not test for endotoxins, residual solvents, or sterility |
| Third-party COAs guarantee product quality | Regulatory guidance (FDA, USP) | Positive, conditional | Moderate | Only true if the COA is from a real, accredited lab. Fabricated COAs exist in the market |
| 503B pharmacy = clinical-grade peptide | FDA regulatory framework (Section 503B of FDCA) | Positive | High (for manufacturing process); does not apply to efficacy | cGMP compliance governs how the product is made, not whether the peptide itself has proven clinical efficacy |
| Lyophilization preserves peptide potency | Pharmaceutical science literature | Positive | High | Stability still depends on reconstitution conditions, storage temperature, and formulation excipients |
| Research peptides sold online are equivalent to clinical-grade compounds | Independent community testing (Janoshik, Janssen Analytical reports) | Highly variable | Low to Very Low | Independent testing has repeatedly found research peptides at below-stated purity or incorrect concentrations |
Tier 1: FDA-Registered Compounding Pharmacies (Prescription Required)
These companies require a valid prescription and operate under FDA or state pharmacy board oversight. This is the appropriate channel for any peptide intended for human use.
1. Empower Pharmacy (Houston, TX)
503B Outsourcing Facility cGMPOne of the largest 503B outsourcing facilities in the country. Registered with the FDA and subject to periodic inspections. Supplies compounded peptides including PT-141 (bremelanotide), Sermorelin, and selected growth hormone secretagogues. Full LAL endotoxin testing and sterility testing documented. Pricing is prescription-dependent and varies by compound. Note: ceased compounding semaglutide products following the 2025 shortage-list removal.
Best for: Patients with a prescribing physician who wants the highest manufacturing accountability available in the compounding channel.
2. Strive Pharmacy (Gilbert, AZ)
503A LicensedState-licensed compounding pharmacy with a notable focus on peptide therapy protocols. Works directly with prescribing practitioners. Offers a broad catalog including CJC-1295, Ipamorelin, and BPC-157 (verify current BPC-157 availability given FDA scrutiny). COA documentation provided at the prescriber level.
Best for: Functional medicine clinics that need reliable prescription fulfillment with practitioner-facing documentation.
3. Tailor Made Compounding (Nicholasville, KY)
503A LicensedLong-standing compounding pharmacy with extensive peptide formulary. Known in the functional medicine space for detailed prescriber support documentation. Operates under Kentucky pharmacy board oversight.
Best for: Physicians who want a broad formulary with prescriber education resources.
4. College Pharmacy (Colorado Springs, CO)
503A LicensedOne of the oldest compounding pharmacies in the US with documented quality systems. Provides PCAB (Pharmacy Compounding Accreditation Board) accreditation, which is the highest voluntary quality standard in the 503A space. PCAB accreditation requires third-party audits of compounding practices.
Best for: Patients who want the added assurance of voluntary third-party accreditation on top of state licensing.
Tier 2: Research-Grade Peptide Vendors (Non-Human Use)
5. Peptide Sciences
Research GradeUS-based vendor with publicly accessible, lot-specific COAs that include HPLC purity data and MS confirmation. States minimum 99% purity for most catalog items. COAs name testing laboratory. One of the more transparent vendors in the research-grade space on documentation standards.
6. Biotech Peptides
Research GradeUS-based synthesis and testing. Provides HPLC and MS COAs per lot. Offers a reasonably broad catalog of research peptides. Cold-chain shipping available. Has maintained consistent purity documentation over multiple independent community testing reports.
7. Umbrella Labs
Research GradeArizona-based vendor. Publicly posts COA documentation. Has been included in independent third-party testing roundups with generally consistent results. Ships within the US with cold-chain packaging options.
8. Core Peptides
Research GradeNewer entrant to the US market with a focus on documentation transparency. Posts COAs with named labs. Competitive pricing without the dramatic undercutting that often signals quality compromise.
9. Pure Rawz
Research GradeBroad catalog including peptides alongside SARMs and nootropics. COA documentation has historically been variable across their catalog. Worth scrutinizing the specific COA for any individual peptide rather than relying on brand-level trust. Not recommended as a first choice for users who prioritize documentation consistency.
10. FormBlends
Compounded FormulationsFormBlends works within the licensed compounding channel, requiring practitioner involvement and providing product-specific documentation. Focuses on formulation quality and transparent ingredient disclosure. Our own placement on this list should be evaluated against the same COA and regulatory criteria we apply to every other entry.
What Most Peptide Comparison Pages Get Wrong
This is the section competitors skip entirely.
Affiliate-driven rankings. The majority of "top 10 peptide companies" articles are built around affiliate commission structures. The company that pays the highest commission per sale ranks first, regardless of COA quality. You can identify these pages because they use language like "our top pick" without specifying a single testable criterion.
No distinction between tiers. Placing a 503B pharmacy and an unregulated research vendor in the same ranked list without explaining the legal and quality gap between them is misleading. They are not comparable products.
Static purity claims. A COA from 18 months ago does not tell you what is in the product you are buying today. Batch-to-batch variation is real. Always request or verify the COA for the current lot number on the product you are purchasing.
Ignoring endotoxin. HPLC purity and mass spectrometry confirm the peptide is present and correct. They say nothing about bacterial endotoxin contamination, which is a genuine risk for any injectable compound synthesized without cGMP controls. LAL endotoxin testing is frequently absent from research-grade vendor COAs and almost never mentioned in comparison articles.
Conflating "legal" with "safe." A research-grade peptide labeled "not for human use" is not the same as a pharmaceutical-grade compound. The label is a legal instrument, not a safety statement.
How to Read a Peptide COA Yourself
A COA you cannot evaluate is not evidence of anything. Here is what each section means:
| COA Field | What to Look For | Red Flag |
|---|---|---|
| Testing Laboratory Name | A named, findable lab (searchable online, has its own website) | No lab name, or a lab name that does not appear to exist |
| Lot / Batch Number | Matches the lot number on your product label | No lot number, or a lot number you cannot cross-reference |
| HPLC Purity | 98% or above; method stated (UV detection wavelength noted) | Purity stated but no chromatogram visible, or purity below 95% |
| Mass Spectrometry (MS) | Observed molecular weight matches theoretical MW of the peptide | No MS data; or MS present but no comparison to expected MW |
| Endotoxin (LAL) | Value stated in EU/mg or EU/mL; below USP limits for the intended route | Absent from COA entirely (common in research-grade products) |
| Test Date | Within 12 to 18 months; matches or post-dates manufacture date | Undated, or older than 24 months without re-test documentation |
Head-to-Head: Research Vendor vs. Compounding Pharmacy
| Criterion | Research-Grade Vendor | 503A Compounding Pharmacy | 503B Outsourcing Facility |
|---|---|---|---|
| FDA Oversight | None (not FDA-regulated as drugs) | State pharmacy board; limited FDA oversight | FDA-registered; cGMP required; periodic inspections |
| Prescription Required | No | Yes | Yes (or institutional order) |
| Endotoxin Testing | Rarely included | Required for sterile compounds under USP standards | Required under cGMP |
| Sterility Testing | Not standard | Required for sterile preparations | Required under cGMP |
| Cost to Patient | Lower | Moderate | Moderate to higher |
| Legal Status for Human Use | Not approved; gray area | Legal with valid prescription | Legal with valid prescription or institutional order |
| Where Research Vendor Loses | Sterility, endotoxin, regulatory accountability, prescriber involvement | n/a | n/a |
Why Storage and Shipping Chemistry Actually Matter
Most peptide comparison pages say "store cold" without explaining why. Here is the actual chemistry.
Peptides are amino acid chains held together by peptide bonds. Two degradation pathways dominate:
Oxidation primarily affects methionine, cysteine, and tryptophan residues. Oxygen reacts with the sulfur-containing side chains of methionine and cysteine, producing sulfoxide or sulfone derivatives that no longer bind target receptors with the same affinity. Elevated temperature accelerates this reaction significantly. Light (UV) is a co-factor in oxidative degradation, which is why amber vials matter.
Hydrolysis cleaves the peptide bond itself, especially at aspartate-proline sequences and at any peptide bond adjacent to a charged residue under non-neutral pH. Water is the reactant, which is why lyophilized (freeze-dried) peptides are far more stable than peptides in solution: removing water removes the reactant for hydrolysis.
This is why: (a) lyophilized peptides are the gold standard form for storage and shipping, (b) minus 20 degrees Celsius is the recommended storage temperature because it slows both oxidation and any residual hydrolysis from trace moisture, and (c) once you reconstitute a peptide in bacteriostatic water, you have reintroduced the hydrolysis reactant. Reconstituted peptides should be used within weeks, not months.
During shipping, a vendor who uses ambient packaging is exposing lyophilized peptides to temperatures that may reach 30 to 40 degrees Celsius in summer transit. This does not guarantee degradation, but it increases the probability of oxidative damage, especially for methionine-containing peptides.
Legal Landscape: What Changed in 2024 to 2026
Semaglutide (2025). The FDA declared the shortage of semaglutide resolved in early 2025. Under Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act, compounding is generally not permitted when a commercially available drug is not in shortage. This effectively ended most legitimate compounded semaglutide production, with limited exceptions for specific patient needs. Vendors still openly selling compounded semaglutide without prescription as of 2026 are operating outside this framework.
BPC-157. The FDA included BPC-157 on its list of bulk drug substances that may not be used in compounding (the "Category 2" list under Section 503A). This means licensed 503A pharmacies cannot legally compound BPC-157. Research-grade vendors continue to supply it under the "not for human use" framework. The compound has not been approved for any human indication by the FDA.
Tirzepatide. As of mid-2025, the FDA also resolved the tirzepatide shortage, applying the same compounding restrictions. Verify current status before assuming any compounded GLP-1 or GIP/GLP-1 agonist product is legally produced.
WADA status. Multiple peptides in the research-grade market, including GHRP-2, GHRP-6, CJC-1295, and Ipamorelin, are prohibited in sport under the WADA Prohibited List as growth hormone secretagogues. Athletes subject to drug testing should treat any peptide purchase with the same scrutiny they would apply to any banned substance.
FAQ
What should I look for in a USA peptide company?
Look for HPLC purity documentation at or above 98%, mass spectrometry confirmation of molecular identity, third-party certificates of analysis from named ISO-accredited labs, clearly stated regulatory category (research compound vs. compounded medication), cold-chain shipping, and transparent sourcing disclosures.
Are peptide companies in the USA regulated by the FDA?
It depends on how the peptide is sold. Research-use peptides sold with "not for human use" labeling are not FDA-approved drugs. Peptides compounded by licensed 503A or 503B pharmacies operate under FDA oversight. The legal category varies by compound and how it is marketed.
What is a certificate of analysis (COA) and why does it matter?
A COA is a document from a testing laboratory confirming purity, identity, and often endotoxin levels. For peptides, a meaningful COA includes HPLC purity percentage, mass spectrometry confirming the correct molecular weight, and the name of the testing lab so you can verify it exists.
What purity level is acceptable for research peptides?
The research peptide industry convention is greater than or equal to 98% purity by HPLC. Some companies offer greater than 99% for select compounds. Anything below 95% is a meaningful quality concern, and vendors who do not specify purity should be avoided entirely.
How do I verify a peptide COA is real and not fabricated?
Cross-check the lab name on the COA against the lab's own website. Legitimate labs are findable and can be contacted. A COA that lists no lab name, no date, and no lot number is not credible.
What is the difference between a 503A and 503B compounding pharmacy for peptides?
503A pharmacies compound for individual patient prescriptions and are state-licensed. 503B outsourcing facilities compound larger batches without patient-specific prescriptions and are registered with the FDA, subject to current Good Manufacturing Practice (cGMP) standards. 503B generally carries higher manufacturing quality assurance.
Why did the FDA restrict certain peptides like BPC-157 and semaglutide from compounding?
The FDA removed semaglutide from the drug shortage list in 2025, triggering a compounding ban for most 503A and 503B pharmacies. BPC-157 was placed on the FDA's list of bulk drug substances that may not be compounded because it has not been evaluated for safety and efficacy as a drug. Always verify current status before purchasing.
What peptides are currently most commonly supplied by US research companies?
Common research-category peptides supplied by US vendors include Epithalon, Selank, Semax, TB-500, CJC-1295, Ipamorelin, PT-141, KPV, and LL-37. Note that several of these are also under FDA or WADA scrutiny, so legal status can change.
What red flags indicate a low-quality peptide supplier?
Red flags include: no publicly accessible COA or a COA with no named lab, prices dramatically below market, no cold-chain shipping option for lyophilized peptides, customer service that cannot answer questions about synthesis method, and no clear statement of the product's legal or regulatory category.
Is it legal to buy peptides online in the USA?
Purchasing research-grade peptides labeled "not for human use" occupies a legal gray area. They are not approved drugs, but they are also not explicitly illegal to purchase for non-human research. Compounded peptides require a valid prescription. Consult a licensed healthcare provider and attorney familiar with your jurisdiction before purchasing.
How should peptides be stored and why does it matter for quality?
Lyophilized peptides are most stable when stored at minus 20 degrees Celsius or colder, away from light and moisture. Once reconstituted in bacteriostatic water, they should be refrigerated at 2 to 8 degrees Celsius and used within a few weeks. Improper storage accelerates oxidation and peptide bond hydrolysis, degrading both potency and safety.
Can I trust a peptide company that ships internationally to the USA?
International suppliers carry additional risks: customs seizure, cold-chain breaks during transit, and no US regulatory recourse if the product is mislabeled or contaminated. US-based synthesis and testing, while not a guarantee of quality, provides at least a domestic legal framework for accountability.
Sources
- US Food and Drug Administration. "Compounding and the FDA: Questions and Answers." FDA.gov. Updated 2024.
- US Food and Drug Administration. "Drug Compounding: 503B Outsourcing Facilities." FDA.gov.
- US Food and Drug Administration. "Bulk Drug Substances That May Not Be Used in Compounding Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act." Federal Register, various years.
- US Food and Drug Administration. "FDA Announces Action to Remove Semaglutide From Drug Shortage List." FDA.gov, 2025.
- World Anti-Doping Agency. "Prohibited List 2026." WADA-AMA.org.
- USP General Chapter 71 (Sterility Tests) and Chapter 85 (Bacterial Endotoxins Test). United States Pharmacopeia.
- Pharmacy Compounding Accreditation Board. "PCAB Accreditation Standards." PCAB.org.
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. "Stability of Protein Pharmaceuticals: An Update." Pharmaceutical Research, 2010. PMID 19921492. (Background on peptide degradation pathways.)
- Federal Food, Drug, and Cosmetic Act, Section 503A and Section 503B. 21 U.S.C.
- Janoshik Testing. Independent third-party testing reports for research compounds. Janoshik.com. (Community-sourced testing referenced in context of research-grade vendor evaluations; individual reports vary by compound and date.)
Footer Disclaimers
Platform Disclaimer: FormBlends is an informational and formulation platform. This page is for educational purposes only. Nothing on this page constitutes medical advice, a treatment recommendation, or an endorsement of any specific product or vendor for human use.
Research Compound or Compounded Medication Disclaimer: Some peptides discussed on this page are sold as research compounds labeled "not for human use." Others are available only through licensed compounding pharmacies with a valid prescription. These are legally and qualitatively distinct categories. Do not conflate them. Verify the legal status of any compound in your jurisdiction before purchasing.
Results Disclaimer: Peptides discussed on this page vary widely in their evidence base. The presence of a vendor on this list does not imply that any product they sell has proven safety or efficacy for any human health condition. Evidence quality ranges from human clinical data to animal and in vitro studies only. Consult a licensed healthcare provider before initiating any peptide therapy.
Trademark Disclaimer: All company names referenced on this page are the trademarks or registered trademarks of their respective owners. Their inclusion is for informational comparison purposes only and does not imply affiliation with or endorsement by FormBlends.